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Abstract:  Substantial losses of nutrients may occur during tube (gavage) feeding of 
fortified human milk. Our objective was to compare the losses of key macronutrients and 
minerals based on method of fortification and gavage feeding method. We used clinically 
available gavage feeding systems and measured pre- and post-feeding (end-point) nutrient 
content of calcium (Ca), phosphorus (Phos), protein, and fat. Comparisons were made 
between continuous, gravity bolus, and 30-minute infusion pump feeding systems, as well 
as human milk fortified with donor human milk-based and bovine milk-based human milk 
fortifier using an in vitro model. Feeding method was significantly associated with fat and 
Ca losses, with increased losses in continuous feeds. Fat losses in continuous feeds were 
substantial, with 40 ± 3 % of initial fat lost during the feeding process. After correction for 
feeding method, human milk fortified with donor milk-based fortifier was associated with 
significantly less loss of Ca (8 ± 4% vs. 28 ± 4%, p< 0.001), Phos (3 ± 4% vs. 24 ± 4%,  
p < 0.001), and fat (17 ± 2% vs. 25 ± 2%, p = 0.001) than human milk fortified with a 
bovine milk-based fortifier (Mean ± SEM).  
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1. Introduction  
Human milk is the recommended feeding for nearly all infants including very low birth weight 
(VLBW) infants. VLBW infants fed human milk, especially their own mother’s milk, have lower rates 
of infection and necrotizing enterocolitis, improved neurologic outcome, and improved feeding 
tolerance [1-7]. Although human milk is optimal for VLBW infants, it is necessary to fortify it with 
macronutrients and minerals in order to meet the nutritional needs of premature infants [8]. Currently, 
powdered bovine milk-based fortifiers are used in most neonatal intensive care units (NICU). Prolacta 
Bioscience (Monrovia, CA) has begun marketing human milk-based nutritional products to preterm 
infants in the US. The company produces both donor milk and a fortifier made from donated milk 
designed to meet the macronutrient and micronutrient needs of preterm infants [9]. Recently, there has 
been increasing use of this fortifier which only contains human milk proteins with the goal of 
improved feeding tolerance. The fortifier can be added to donor milk or mother’s own milk as a high 
calorie, high mineral-containing liquid.  
Regardless of the fortifier used, fortified human milk (FHM) is usually delivered via gavage until 
the infant is able to feed orally. Milk provided by gavage feeding may be delivered via a variety of 
methods. These include gravity bolus, in which the feedings are allowed to drip over 10–15 minutes 
into the infant; via infusion using an infusion pump set to deliver the milk over a set time, typically 30-
60 minutes; or via continuous feeding, using an infusion pump or commercially available roller head 
pump. Each of these methods is used widely and often one infant will receive multiple approaches to 
feeding during their hospitalization. There are limited data to indicate that any one method is superior 
to another. Use of any of these methods may lead to substantial loss of nutrients. Limited data related 
to feeding method and nutrient losses were published previously, but these older studies do not reflect 
current feeding and delivery systems [10-15]. There have been no recent publications evaluating 
nutrient losses. In general, nutrient intake calculations as performed in a NICU setting do not account 
for the nutrient losses associated with gavage feeding. Knowledge of the loss of nutrients incurred 
during the gavage process is necessary in order to accurately assess nutrient intake and the effect of 
nutritional interventions. 
Our NICU has begun use of human milk-based fortifier as a part of research protocols. Some of the 
staff have noted that there is less visible separation of human milk and adherence to the delivery 
system when using these products. This encouraged us to study if nutrient delivery is different in 
human milk fortified with human milk-based fortifiers and bovine milk-based fortifiers, and how the 
delivery systems affect nutrient delivery. Therefore, we sought to clarify the nutrient losses that occur 
during the delivery process of fortified human milk by creating in vitro a tube feeding system that 
simulates the usual NICU feeding methods in our unit. With this system we assessed the nutrient 
losses from fortified human milk of different forms and via different feeding approaches. We 
evaluated losses of key nutrients: fat, protein, calcium, and phosphorous. Fat and Protein were chosen 




calories) [16]. Calcium and phosphorous were chosen as these minerals often complex with fat and 
deficiencies can lead to osteopenia or rickets in preterm infants [17]. 
Our primary aim was to compare the losses of key macronutrients and minerals based on method of 
fortification and gavage feeding method in infants fed fortified human milk. Secondary aims were to 
provide information useful to assess actual nutrient intakes and to provide a basis for determining 
potential needs for improvement in milk delivery systems. 
2. Experimental Section 
2.1. Simulated Feedings 
 
We evaluated the use of both human milk fortified with donor human milk-based fortifier (HM-
DonF) and human milk fortified with bovine milk-based fortifier (HM-BovF) using an in vitro model 
of stimulated feedings. Banked, unprocessed donor human milk (Prolacta Bioscience, Monrovia, CA) 
stored at −20 
oC was thawed and then mixed with either bovine-based human milk fortifier (Similac 
Human Milk Fortifier, Abbott Laboratories, Columbus, OH) or donor human milk-based human milk 
fortifier (Prolact +4 H2MF, Prolacta Bioscience, Monrovia, CA) per manufacturers instructions to 
achieve approximately 81 kcal/100 mL final concentration. All mothers were human milk donors prior 
to study inception and had given written informed consent for use of their milk for consumption and/or 
general research purposes upon donation to Prolacta Bioscience. Institutional Review Board approval 
was not necessary because only pooled, non-identifiable milk samples were used in this study. The 
banked, unprocessed donor milk was frozen and should be considered equivalent to mother’s milk 
provided to infants.  
FHM was separated into aliquots. A “pre” feeding aliquot of 30 mL was immediately processed 
after mixing for analysis of calcium (Ca), phosphorous (Phos), protein, and fat. To simulate conditions 
in the NICU where feedings are often stored after mixing, a second 30 mL aliquot was stored 
overnight (8–16 hours) at 4 
oC, then warmed in a 40 
oC water bath and given as a simulated feeding. 
All simulated feeds were given through a 5 French, 90 cm orogastric feeding tube (Kendall Argyle, 
Tyco Healthcare, Mansfield, MA). The simulated feeding was collected in its entirety and analyzed for 
Ca, Phos, protein and fat as a “post” aliquot. Nutrient loss was expressed as a percentage of initial 
nutrient concentration.  
Simulated feeding conditions included: bolus by gravity at height of 30 cm (n = 15 for each 
fortifier), bolus over 30 minutes by infusion pump (Medfusion 2010, Medex Inc, Duluth, GA) (n = 5 
for each fortifier), and continuous delivery over 3 hours with a commercially available roller head 
pump (Kangaroo 324 and Kangaroo Epump, Sherwood Medical, St.Louis, MO) (n = 15 for each 
fortifier). Boluses given by gravity feeds were oriented in the vertical direction. Boluses given over 30 
minutes by infusion pump feeds were infused at a rate of 60 mL/hr and were oriented in the horizontal 
direction. Continuous infusion feeds ran at a rate of 10 mL/hr.  
The simulated continuous feedings were given through Kangaroo Pump Feeding Bags and tubing 
(with the Kangaroo 324) (n = 5 for each fortifier) or Kangaroo Epump 100 mL Burette Set (with the 
Kangaroo Epump) (n = 10 for each fortifier) in addition to the 5 French orogastric feeding tube. A new 




using the Kanagaroo 324, and transitioned to the Kangaroo Epump for delivery of continuous feeds. 
Data were collected on both systems.  
 
2.2. Nutrient Analysis 
 
2.2.1. Calcium and Phosphorous 
 
FHM aliquots were microwave digested in HNO3 acid, dried and reconstituted with 20 mL of 
ultrapure 0.1N HNO3. Samples were then analyzed in triplicate for total minerals using inductively 
coupled plasma analysis. Average values were determined and used for calculations. Precision and 
accuracy of this method is <5%. 
 
2.2.2. Fat and Protein 
 
FHM aliquots of both donor human milk-based and bovine milk- based fortifier were analyzed by 
the supplier of the donor human milk using mid-range infrared analysis using an Acudairy 5150 (ATI 
Inc., Westfield, NY) that has been calibrated for use with human milk. Precision and accuracy of this 
method is <5%.  
 
2.3. Statistical Analysis 
 
Data were analyzed using SPSS (Version 16, Chicago, Il) and the relationships among nutrient 
losses and other outcome variables evaluated by general linear analysis. All data are presented as mean 
± SEM using pooled variances from the analysis. The interaction of feeding type and delivery method 
was evaluated. If this interaction was significant (p < 0.05), then analysis was performed separately for 
each feeding type. Pair-wise comparisons were performed for significant comparisons (p < 0.05) 
identified in the analysis.  
3. Results and Discussion  
Table 1. Nutrient Composition of 100 mL Fortified Human Milk Prior to Simulated Feeds. 
A.HM-DonF 
 Mean  SEM  Per  Label
18  
Ca (mg)  99.8  4.8  94 
Phos (mg)  60.1  0.7  44 
Fat  (g)  3.7 0.2 4.8 
Protein (g)  2.1  0.03  2 
Values shown reflect HM-DonF at time of study. Mineral composition has been increased 




Table 1. Cont. 
B. HM-BovF 
 Mean  SEM  Per  Label
19 
Ca (mg)  165.4  7.6  138 
Phos (mg)  100.3  3.3  78 
Fat  (g)  3.1 0.2 4.1 
Protein (g)  2.2  0.04  2.3 
Table 2. Endpoint Nutrient Concentration by Fortifier and feeding method (Mean ± SEM). 
A.  HM-DonF 
 Gravity  Infusion  Continuous  324  Continuous 
Epump 
Ca (mg)  96.3 ± 3.3  108.8 ± 1.9  95.1 ± 2.8  87.6 ± 2.5 
Phos (mg)  60.1 ± 0.7  57.5 ± 0.5  57.3 ± 0.8  60.9 ± 1.1 
Fat (g)  3.5 ± 0.2  2.9 ± 0.4  2.2 ± 0.3  3.2 ± 0.1 
Protein (g)  2.1 ± 0  2.0 ± 0.1  2.0 ± 0  2.1 ± 0 
B.  HM-BovF 
 Gravity  Infusion  Continuous  324  Continuous 
Epump 
Ca (mg)  137 ± 11.8  110.3 ± 4.0  62.4 ± 16.9  119.4 ± 17.3 
Phos (mg)  84.9 ± 6.1  68.6 ± 3.4  64.5 ± 32.2  77.6 ± 8.7 
Fat (g)  2.9 ± 0.2  2.4 ± 0.5  1.4 ± 0.3  2.3 ± 0.1 
Protein (g)  2.3 ± 0  2.1 ± 0.1  2.1 ± 0  2.2 ± 0 
Table 3. Percent nutrient losses by fortifier. 
  HM-DonF HM-BovF  p-value 
Number of samples  35 35   
Ca (%)  8 ± 4  28 ± 4  <0.001 
Phos (%)  3 ± 4  24 ± 4  <0.001 
Fat (%)  17 ± 2  25 ±2  0.001 
Protein (%)  0 ± 1  −1 ± 1  0.56 
Values shown are corrected for feeding method. There was no significant interaction of feeding 
method and fortifier type. Data shown are Mean ± SEM using the pooled SEM from   





















30 10  10  20   
Ca (%)  9 ± 4  14 ± 7  33 ± 7  17 ± 5  0.04* 
Phos (%)  7 ± 4  14 ± 6  20 ± 6  12 ± 4  0.35 
Fat (%)  6 ± 2  13 ± 3  40 ± 3  25 ± 2  <0.001** 
Protein (%)  −3 ± 1  0 ± 1  1 ± 2  −1 ± 1  0.10 
Values shown are corrected for fortifier type. There was no significant interaction of feeding 
method and milk type. Data shown are Mean ± SEM using the pooled SEM from ANOVA 
analysis.  
*Interaction term of feeding method and milk type not significant, p = 0.57. Paired difference of 
Grav vs. Cont 324 was significant, p = 0.005, all others p > 0.05. 
**interaction term of feeding method and milk type significant, p = 0.02. All paired comparisons 
are significant, P < 0.01 except for Grav vs. Infusion which is p = 0.06. 
Table 5. Percent fat loss differences based on feeding type and fortification source. 
  HM-DonF HM-BovF p-value 
Number of samples  35 35  
Infusion via gravity  
(n = 15 each) 
6 ± 2  6 ± 2  0.83 
Infusion via pump  
(n = 5 each) 
10 ± 2  16 ± 2  0.10 
Continuous with 324  
(n = 5 each) 
29 ± 4  51 ± 4  0.007 
Continuous with Epump  
(n = 10 each) 
22 ± 4  28 ± 4  0.22 
Table 6. Percent nutrient losses in continuous feeds 





Number of samples 10 20  
Ca (%)  33 ± 8   17 ± 5  0.10 
Phos (%)  20 ± 7  12 ± 5  0.39 
Fat (%)  40 ± 3  25 ± 3  0.003* 
*Interaction term of feeding method and milk type, p = 0.08. Analysis performed including this 
term. 




Figure 1. HM-BovF shows a significant linear relationship for Ca and Phos losses. This is 
not seen for HM-DonF.  





















Table 1 shows the nutrient composition of fortified human milk prior to any simulated feeds. Table 
3 shows the percent nutrient losses in the different fortifiers corrected for feeding method. A 
substantial difference between fortifiers was seen for Ca and Phos, with a smaller but also statistically 
significant difference seen for fat. Protein content changes were minimal and were essentially identical 
between fortifiers.  
Nutrient losses, as related to feeding mechanism, are shown in Table 4. All nutrients were 
maintained at higher levels with more rapid infusions. This was significant for Ca and fat, but did not 
reach significance for Phos. Protein losses were again minimal and not significantly different among 
the feeding mechanisms. In pairwise comparisons, Ca losses were significantly lower using gravity 
compared to continuous feeds (p < 0.05).  
A significant interaction was seen for fat losses between feeding method and fortifier type   
(p = 0.02). We, therefore, evaluated the effects of specific feeding methods on the difference seen in 
human milk fortified with donor milk-based fortifier vs. human milk fortified with bovine milk-based 
fortifier for fat loss. This showed (Table 5) that the significant effect was largely related to the 
Kangaroo 324 continuous pump having very high fat losses. Of importance to note is that no 
differences in fat losses between fortifiers were seen using Gravity bolus feeds. 
We evaluated both the Kangaroo 324 and Kangaroo Epump. The use of the newer Epump markedly 
decreased the loss of fat (Table 6). There were also reduced Ca and Phos losses, but this did not 
achieve statistical significance due to the greater variability in the mineral results. There was no 
difference between the protein losses.  
As shown in Figure 1, a significant linear relationship between Ca and Phos losses was seen overall 
in fortified human milk (r = 0.88, p < 0.001), suggesting direct loss of calcium phosphate salts. 
However, when examining the type of fortifier used, this linear relationship remained significant only 




relationship between Ca and fat losses overall (r = 0.1, p = 0.3) or in HM-DonF (r = 0.1, p = 0.5) or 
HM-BovF (r = 0.03, p = 0.8), further suggesting the loss of calcium primarily as bound to phosphate.  
4. Discussion and Conclusions 
We found substantial losses of key minerals and fat, but not protein, associated with the feeding of 
fortified human milk by gavage. Factors that minimized these losses were the use of liquid donor 
human milk-based fortifier, the use of bolus or infusion over 30 minutes instead of continuous feeds, 
and the use of a newer pump system for the delivery of continuous feeds. We hypothesize that nutrient 
losses could be due to improper mixing, precipitation, adherence to the delivery systems or other 
unknown factors. 
This study confirms that nutrient losses during routine feeding practices in the nursery are still a 
concern and remain similar to those seen in older studies, despite improvements and enhancements of 
human milk fortifiers. This is the first study to evaluate both macronutrient and mineral losses that 
occur in fortified human milk. Furthermore, this is the first comparison of a human milk-based 
fortifier with traditional bovine milk-based fortifier.  
In evaluating the impact of these losses on caloric intake, the effect ranged from as little as 6% of 
fat lost when feeds were given via bolus by gravity to up to 50% of fat lost when powdered bovine 
milk-based fortified human milk was given by continuous feeding using an older pump. Assuming 
approximately 50% calories from fat and intake targets of 120 kcal/kg/d, this would represent from 3 
kcal/kg/d to about 25 kcal/kg/d lost in the feeding. It is important to note that the smallest of infants 
often do not tolerate gravity bolus feedings and feedings are given by gavage over at least 30 minutes 
or by continuous gavage. Our data indicate that this practice may affect the nutrient delivery to these 
vulnerable infants.  
The reason for the significant improvement in fat losses we observed in continuous feeds with the 
Kangaroo Epump compared to the Kangaroo 324 is uncertain. Both pumps use a rotary peristaltic 
method for delivery of feedings. However, the Epump does not have a collection chamber and has 
shorter tubing length. We hypothesize that these factors may have been the reason for significantly 
reduced losses, but further evaluation is needed.  
The linear relationship between Ca and Phos losses was highly significant in human milk fortified 
with a bovine milk-based fortifier with a slope approximating a mg:mg loss. This suggests direct loss 
of calcium phosphate salts in HM-BovF. The mineral losses with fortified human milk indicate that 
the primary issue is likely to be insolubility and adherence in the tubing delivery system. There was no 
evidence of a significant relationship between Ca and fat losses in fortified human milk indicating that 
the losses of Ca are primarily related to added calcium salts rather than the intrinsic human   
milk calcium.  
Previous research also shows marked losses of nutrients from human milk, especially lipids, when 
delivered through simulated feeds [10-14]. However, those studies were all performed over 20 years 
ago and used exclusively unfortified human milk. Brooke (1978) was the first to show losses during 
continuous feeds with variations up to 24% in fat content with recovery of much of the fat content in 
residue and washings of tubing [10]. Using slower infusions and the use of continuous feedings 




losses with the syringe pump in the vertical position for moderate and fast infusion times. Both Greer 
and Narayanan (1984) found an energy rich aliquot at the end of the feed in continuous feeds, but 
Narayanan did not see this with intermittent feeds [12]. Narayanan hypothesized that fat losses were 
minimized by an eccentric nozzle. Stocks (1985) confirmed an inverse correlation between fat loss and 
flow rates [13]. Of note, Stocks evaluated protein losses and found them to be 7% for bolus and 5% 
for continuous feeds. This is in contrast to our relative sparing of protein. We believe the “gain” of 
protein we saw was due to a relative loss of water. All authors cite visible separation of the milk and 
adherence to the tubing as the reason for the substantial losses. There has been a paucity of 
investigation into nutrient losses during gavage feedings since these articles were published, and 
despite improvements in fortifiers over the last 20 years substantial nutrient losses can still be seen. 
Bhatia evaluated mineral losses from premature infant formulas [15]. He found that bolus feeds 
minimized mineral losses in formula (Ca losses were 0–9%, and Phos losses were relative gain of 2 to 
a loss of 8%). Depending on the formula, 25–41% of the calcium was lost, and relative gain of 2% to 
loss of 33% of the phosphorous was seen in continuous feeds. To our knowledge, there are no 
previous studies that examine the mineral losses encountered during routine nursery feeding practices 
of human milk. Our results in fortified human milk indicate that approx 9% of Ca is lost and 7% of 
Phos is lost in bolus by gravity feeds and 17–33% of Ca is lost, and 12–20% of Phos is lost in 
continuous feeds. These numbers are similar to the losses seen in formula. The majority of the Ca and 
Phos in fortified human milk are supplied by the fortifier. Since many of the salts that are added to the 
fortifiers are the same salts that are added to preterm formula, these results are not surprising.  
Our primary aim was to compare the losses of nutrients based on method of fortification and 
gavage feeding method. We strove to determine if any substantial improvement in nutrient losses has 
occurred in the last 20 years. In an attempt to be consistent with previous studies, we reported the data 
in terms of percent loss. Use of percent loss is also helpful as the donor milk based fortifier product 
recently increased their mineral concentration. We performed the study on the older formulation. 
Mineral composition has been increased to 112 mg Ca and 53 mg Phos per 100 mL fortified human 
milk. It is possible that this change in mineral levels could affect losses, but since a direct loss of 
calcium phosphate salts was not seen in HM-DonF, we believe this is unlikely. Furthermore, the donor 
milk based fortifier uses the same calcium salts and emulsifiers as were used prior to the 
reformulation, leading to minimal change in percentage loss. However the use of percent loss may 
mask the true final concentration of nutrients that are present. For this reason we have included the 
initial and endpoint nutrient concentrations.  
This study did not evaluate other losses, nutritive and non-nutritive in nature (e.g., vitamins, 
immunoglobins, etc.). Additionally, we did not look for a bolus of fat delivered at the end of the 
feeding, or for the ability to recover nutrients from the feeding syringe or tubing. However, our study 
design was intended to simulate actual feeding conditions and therefore post-feeding recovery of 
nutrients was not our goal. An additional limitation is that a new feeding tube was used for each 
simulated feed. In clinical practice indwelling gavage tubes are often used for more than one feed. The 
nutrient losses seen in our study may not represent the losses seen over the life of the feeding tube.  
Nutrient losses from delivery method and fortifier type may be contributing factors to poor growth 
in the human milk fed neonate. The substantial losses that we have shown during the gavage feeding 




infants; this is especially true for continuous feedings of fortified human milk. Further research is 
necessary to investigate factors that limit these losses. Although some infants may tolerate feedings 
better when given continuously, evidence to support the routine use of this practice in VLBW infants 
is minimal [20,21]. In deciding on nursery practices, the loss of nutrients during continuous feedings 
of fortified human milk should be considered. Nutrient intake calculations may need to reflect these 
losses and consideration should be given to avoiding only using long-term continuous feeds in infants 
who are at nutritional risk. 
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